| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells
|
Grille, Sofía
|
|
2009
|
59 |
4 |
p. 519-527
|
artikel
|
| 2 |
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
|
Seliger, Barbara
|
|
2009
|
59 |
4 |
p. 529-540
|
artikel
|
| 3 |
CD4+CD45RA+CXCR4+ lymphocytes are inversely associated with progression in stages I–III melanoma patients
|
Napolitano, Maria
|
|
2009
|
59 |
4 |
p. 511-517
|
artikel
|
| 4 |
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties
|
Verma, Bhavna
|
|
2009
|
59 |
4 |
p. 563-573
|
artikel
|
| 5 |
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells
|
Popmihajlov, Zoran
|
|
2009
|
59 |
4 |
p. 629-633
|
artikel
|
| 6 |
Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
|
Dai, Jianxin
|
|
2010
|
59 |
4 |
p. 641-642
|
artikel
|
| 7 |
ESCII–PIVAC meeting “Recent advances in cancer immunotherapy with an emphasis on cancer vaccines” held in Athens, 9–11 October 2008
|
Umansky, Viktor
|
|
2009
|
59 |
4 |
p. 635-640
|
artikel
|
| 8 |
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release
|
Rolin, Johannes
|
|
2009
|
59 |
4 |
p. 575-586
|
artikel
|
| 9 |
Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
|
Rech, Andrew J.
|
|
2009
|
59 |
4 |
p. 599-607
|
artikel
|
| 10 |
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model
|
Ginzkey, Christian
|
|
2009
|
59 |
4 |
p. 541-551
|
artikel
|
| 11 |
Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells
|
Janetzki, Sylvia
|
|
2009
|
59 |
4 |
p. 609-618
|
artikel
|
| 12 |
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer
|
Passalacqua, Rodolfo
|
|
2009
|
59 |
4 |
p. 553-561
|
artikel
|
| 13 |
Regulation of immunity and oncogenesis by the IRF transcription factor family
|
Savitsky, David
|
|
2010
|
59 |
4 |
p. 489-510
|
artikel
|
| 14 |
Regulation of immunity and oncogenesis by the IRF transcription factor family
|
Savitsky, David
|
|
|
59 |
4 |
p. 489-510
|
artikel
|
| 15 |
Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program
|
Mander, A.
|
|
2010
|
59 |
4 |
p. 619-627
|
artikel
|
| 16 |
Type I interferons inhibit the generation of tumor-associated macrophages
|
U’Ren, Lance
|
|
2009
|
59 |
4 |
p. 587-598
|
artikel
|
Tijdschrift beschrijving